RespireRx Pharmaceuticals Inc (fka RSPI)

[enemem]

Over the years following this stock, there were a variety of people who proposed a range of "technical analysis" predictions of future share price based on past trading patterns, from tea-cups to bouncing dead cats. Here finally we have a stock where only a lunatic could predict a recovery in share price, so it's like a physics experiment in a bubble chamber. I think most of the ripple is due to the slowness of over-the-counter trading, but still it's nice to watch.

On the nail-in-the-coffin front, the whole notion of building a company around cannabis extracts/analogs/derivatives seems foolish: the drug is on the way to being legalized. The deep knowledge-base accrued by generations of potheads, who have developed strains with a broad range of psychoactive and bioactive ingredients, as well as a good understanding of how different modes of ingestion affect the subject's exposure to these ingredients means that means that any pharma developing cannabis-based drugs will be in competition with dispensaries.